Enlyt Health's low code mobile platform for Digital Front Doors is now available in the EPIC App Market
ST. PETERSBURG, Fla. - January 25, 2022 - (Newswire.com)
Enlyt Health, the leading Low Code Mobile Platform as a Service for Healthcare, announced that it has partnered with Epic to offer its platform on the App Market.
"We're delighted to join an amazing Marketplace and offer easy access to Enlyt Health Platform," said Scott Fielder, Enlyt Health's Founder and Chief Executive Officer. "Giving Health Systems the opportunity to expand on their Digital Front Door footprint and utilize the amazing power that Epic currently provides is a huge win for all sides. By joining the App Market, we're able to bring enhanced patient experience directly to Epic patients in a clean and simplified way, making it easier for patients to make informed care decisions in real-time."
The Enlyt Health platform has been recognized by healthcare systems for its innovation in the Digital Front Door experience and improving patient experience. All Epic community members can now explore and access Enlyt Health platform in the App Market.
About Enlyt Health
Enlyt Health helps organizations build Digital Front Doors faster by providing a Low Code Mobile Platform that breaks down silos, provides brand recognition, removes disjointed end-user frustration and enhances patient experience all in one future innovation-focused platform. Customers can deploy their Digital Front Door mobile application in as little as 90 days delivering exponentially higher ROI than ground-up builds, the comfort of knowing their applications are built on an industry-proven platform and know their patients are getting industry-leading patient engagement. Learn more at www.enlythealth.com.
The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
AcCELLerate Forum The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
MILWAUKEE, September 21, 2023 (Newswire.com)
-
- AcCELLerate Forum, a partnership between Center for International Blood and Marrow Transplant Research (CIBMTR), the American Society for Transplantation and Cellular Therapy (ASTCT), and the National Marrow Donor Program (NMDP)/Be The Match, will bring key stakeholders together to identify ongoing needs and opportunities in cell and gene therapy for advocacy, measurement of value, impact, and sustainability. The Oct. 2-3, workshop at the Sheraton Pentagon City Hotel in Arlington, VA, and online will bring together providers, payers, government agencies, and industry members to define essential factors needed to create a sustainable cell and gene therapy ecosystem.
"CIBMTR is proud to co-sponsor this important forum that interests all key stakeholders across the ecosystem," said Marcelo Pasquini, MD, MS, Senior Scientific Director, CIBMTR MCW. "Our established relationships with a global network of treatment centers and cell and gene therapy developers uniquely position CIBMTR to bring these experts together to identify the needs and opportunities to adapt to this rapidly evolving field.”
CIBMTR will join industry leaders, treatment-center partners, regulators, and other professionals to discuss the regulatory landscape for the approval of new products. The participants will focus on the perspectives of the payer and regulators, data acquisition and analysis, and center perspectives in defining outcomes for CAR-T cells. They will also discuss logistics for CAR-T, safety and toxicity, and the future directions and competing therapies. The forum will also include breakout sessions on the logistics of cell therapy delivery, efficacy, treatment decisions and sequencing, and manufacturing and logistics standardization in a moderator-led roundtable with attendee participation. Visit the event website to register.
Eligible members of the media are invited to attend AcCELLerate Forum in-person or online at no cost. Please contact Jennifer Kasowicz ([email protected]), Director of Marketing at ASTCT, at (312) 673-4970, to verify eligibility and receive the passcode.
About CIBMTR The Center for International Blood and Marrow Transplant Research (CIBMTR) is a nonprofit research collaboration between the NMDP/Be The Match, in Minneapolis, and the Medical College of Wisconsin, in Milwaukee. CIBMTR collaborates with the global scientific community to increase survival and enrich the quality of life for patients. CIBMTR facilitates critical observational and interventional research through scientific and statistical expertise, a large network of centers, and a unique database of long-term clinical data for more than 635,000 people who have received hematopoietic cell transplantation and other cellular therapies. Learn more at cibmtr.org.
About ASTCT
The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of more than 3,000 physicians, investigators, and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. For more information about ASTCT, visit www.astct.org and follow us on Twitter, @ASTCT.
About NMDP/Be The Match
The National Marrow Donor Program (NMDP)/Be The Match is the leading global partner working to save lives through cellular therapy. With 35 years of experience managing the most diverse registry of potential unrelated blood stem cell donors and cord blood units in the world, NMDP/Be The Match is a proven partner in providing cures to patients with life-threatening blood and marrow cancers and diseases. Through their global network, they connect centers and patients to their best cell therapy option—from blood stem cell transplant to a next-generation therapy—and collaborate with cell and gene therapy companies to support therapy development and delivery through Be The Match BioTherapies.
Contact Information:
Jennifer Kasowicz
ASTCT Marketing Director [email protected]
(312) 673-4970
